Magnetic Resonance Elastography and Other Magnetic Resonance Imaging Techniques in Chronic Liver Disease: Current Status and Future Directions

키워드

참고문헌 (104)

1. Jézéquelemail C, "P0709: survival of patients infected by chronic hepatitis C and F0F1 fibrosis at baseline after a 15 year follow-up", J Hepatol, 62(2), pp.S589~ (2015)
2. Maharaj B, "Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver", Lancet, 1, pp.523~525 (1986)
3. Piccinino F, "Complications following percutaneous liver biopsy: a multicentre retrospective study on 68,276 biopsies", J Hepatol, 2, pp.165~173 (1986)
4. Venkatesh SK, "Magnetic resonance elastography of liver: technique, analysis, and clinical applications", J Magn Reson Imaging, 37, pp.544~555 (2013)
5. Manduca A, "Spatio-temporal directional filtering for improved inversion of MR elastography images", Med Image Anal, 7, pp.465~473 (2003)
6. Rusak G, "Whole-organ and segmental stiffness measured with liver magnetic resonance elastography in healthy adults: significance of the region of interest", Abdom Imaging, 40, pp.776~782 (2015)
7. Marcellin P, "Fibrosis and disease progression in hepatitis C", Hepatology, 36(5 Suppl 1), pp.S47~S56 (2002)
8. Lee VS, "Magnetic resonance elastography and biomarkers to assess fibrosis from recurrent hepatitis C in liver transplant recipients", Transplantation, 92, pp.581~586 (2011)
9. Huwart L, "Magnetic resonance elastography for the noninvasive staging of liver fibrosis", Gastroenterology, 135, pp.32~40 (2008)
10. Hallinan JT, "Magnetic resonance elastography of liver: influence of intravenous gadolinium administration on measured liver stiffness", Abdom Imaging, 40, pp.783~788 (2015)
11. Motosugi U, "Effects of gadoxetic acid on liver elasticity measurement by using magnetic resonance elastography", Magn Reson Imaging, 30, pp.128~132 (2012)
12. Venkatesh SK, "Magnetic resonance elastography for the detection and staging of liver fibrosis in chronic hepatitis B", Eur Radiol, 24, pp.70~78 (2014)
13. Huwart L, "Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index", Radiology, 245, pp.458~466 (2007)
14. Bonekamp S, "Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately?", J Hepatol, 50, pp.17~35 (2009)
15. Chen J, "Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography", Radiology, 259, pp.749~756 (2011)
16. Venkatesh SK, "Non-invasive detection of liver fibrosis: MR imaging features vs. MR elastography", Abdom Imaging, 40, pp.766~775 (2015)
17. Loomba R, "Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study", Hepatology, 60, pp.1920~1928 (2014)
18. Yin M, "Hepatic MR elastography: clinical performance in a series of 1377consecutive examinations", Radiology, 278, pp.114~124 (2015)
19. Singh S, "Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data", Clin Gastroenterol Hepatol, 13(e6), pp.440~451 (2015)
20. Shire NJ, "Test-retest repeatability of MR elastography for noninvasive liver fibrosis assessment in hepatitis C", J Magn Reson Imaging, 34, pp.947~955 (2011)
21. Park HS, "Three-Tesla magnetic resonance elastography for hepatic fibrosis: comparison with diffusion-weighted imaging and gadoxetic acidenhanced magnetic resonance imaging", World J Gastroenterol, 20, pp.17558~17567 (2014)
22. Mannelli L, "Magnetic resonance elastography:feasibility of liver stiffness measurements in healthy volunteers at 3T", Clin Radiol, 67, pp.258~262 (2012)
23. Serai SD, "Cross-vendor validation of liver magnetic resonance elastography", Abdom Imaging, 40, pp.789~794 (2015)
24. Kim D, "Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography", Radiology, 268, pp.411~419 (2013)
25. Taouli B, "Advanced MRI methods for assessment of chronic liver disease", AJR Am J Roentgenol, 193, pp.14~27 (2009)
26. Mariappan YK, "MR elastography of liver with iron overload: development, evaluation and preliminary clinical experience with improved spin echo and spin echo EPI sequences", Proceedings of the 21st Annual ISMRM Conference, pp.20~26 (2013)
27. Arena U, "Acute viral hepatitis increases liver stiffness values measured by transient elastography", Hepatology, 47, pp.380~384 (2008)
28. Yin M, "Dynamic postprandial hepatic stiffness augmentation assessed with MR elastography in patients with chronic liver disease", AJR Am J Roentgenol, 197, pp.64~70 (2011)
29. Ichikawa S, "Hepatitis activity should be considered a confounder of liver stiffness measured with MR elastography", J Magn Reson Imaging, 41, pp.1203~1208 (2015)
30. Venkatesh SK, "Correlation of MR elastography with morphometric quantification of liver fibrosis (Fibro-C-Index) in chronic hepatitis B", Magn Reson Med, 72, pp.1123~1129 (2014)
31. Ichikawa S, "Magnetic resonance elastography for staging liver fibrosis in chronic hepatitis C", Magn Reson Med Sci, 11, pp.291~297 (2012)
32. Shi Y, "MR elastography for the assessment of hepatic fibrosis in patients with chronic hepatitis B infection:does histologic necroinflammation influence the measurement of hepatic stiffness?", Radiology, 273, pp.88~98 (2014)
33. Castera L, "Noninvasive assessment of liver fibrosis", Dig Dis, 33, pp.498~503 (2015)
34. Sandrin L, "Transient elastography:a new noninvasive method for assessment of hepatic fibrosis", Ultrasound Med Biol, 29, pp.1705~1713 (2003)
35. Castéra L, "Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C", Gastroenterology, 128, pp.343~350 (2005)
36. Myers RP, "Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients", Hepatology, 55, pp.199~208 (2012)
37. Foucher J, "Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations", Eur J Gastroenterol Hepatol, 18, pp.411~412 (2006)
38. Cui XW, "Liver elastography, comments on EFSUMB elastography guidelines 2013", World J Gastroenterol, 19, pp.6329~6347 (2013)
39. Tang A, "Ultrasound elastography and MR elastography for assessing liver fibrosis: part 2, diagnostic performance, confounders, and future directions", AJR Am J Roentgenol, 205, pp.33~40 (2015)
40. Perumpail RB, "MRI-guided biopsy to correlate tissue specimens with MR elastography stiffness readings in liver transplants", Acad Radiol, 19, pp.1121~1126 (2012)
41. Kamphues C, "Viscoelasticity-based magnetic resonance elastography for the assessment of liver fibrosis in hepatitis C patients after liver transplantation", Rofo, 184, pp.1013~1019 (2012)
42. Talwalkar J, "Feasibility of in vivo MR elastographic splenic stiffness measurements in the assessment of portal hypertension", AJR Am J Roentgenol, 193, pp.122~127 (2009)
43. Ronot M, "Assessment of portal hypertension and high-risk oesophageal varices with liver and spleen three-dimensional multifrequency MR elastography in liver cirrhosis", Eur Radiol, 24, pp.1394~1402 (2014)
44. Nedredal GI, "Portal hypertension correlates with splenic stiffness as measured with MR elastography", J Magn Reson Imaging, 34, pp.79~87 (2011)
45. Low G, "Magnetic resonance elastography in the detection of hepatorenal syndrome in patients with cirrhosis and ascites", Eur Radiol, 25, pp.2851~2858 (2015)
46. Adams LA, "The natural history of nonalcoholic fatty liver disease: a population-based cohort study", Gastroenterology, 129, pp.113~121 (2005)
47. Chalasani N, "The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology", Gastroenterology, 142, pp.1592~1609 (2012)
48. Ratziu V, "Sampling variability of liver biopsy in nonalcoholic fatty liver disease", Gastroenterology, 128, pp.1898~1906 (2005)
49. Lee SS, "Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations", J Hepatol, 52, pp.579~585 (2010)
50. van Werven JR, "Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and pointresolved 1H MR spectroscopy", Radiology, 256, pp.159~168 (2010)
51. Hepburn MJ, "The accuracy of the report of hepatic steatosis on ultrasonography in patients infected with hepatitis C in a clinical setting: a retrospective observational study", BMC Gastroenterol, 5, pp.14~ (2005)
52. Strauss S, "Interobserver and intraobserver variability in the sonographic assessment of fatty liver", AJR Am J Roentgenol, 189, pp.W320~W323 (2007)
53. Artz NS, "Reproducibility of MRbased liver fat quantification across field strength: same-day comparison between 1.5T and 3T in obese subjects", J Magn Reson Imaging, 42, pp.811~817 (2015)
54. Noureddin M, "Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials", Hepatology, 58, pp.1930~1940 (2013)
55. Dong Z, "MR quantification of total liver fat in patients with impaired glucose tolerance and healthy subjects", PloS One, 9, pp.e111283~ (2014)
56. Tang A, "Effects of insulin glargine and liraglutide therapy on liver fat as measured by magnetic resonance in patients with type 2 diabetes: a randomized trial", Diabetes Care, 38, pp.1339~1346 (2015)
57. Patel NS, "Effect of weight loss on magnetic resonance imaging estimation of liver fat and volume in patients with nonalcoholic steatohepatitis", Clin Gastroenterol Hepatol, 13(e1), pp.561~568 (2015)
58. Idilman IS, "Impact of sequential proton density fat fraction for quantification of hepatic steatosis in nonalcoholic fatty liver disease", Scand J Gastroenterol, 49, pp.617~624 (2014)
59. Kang BK, "Hepatic fat quantification: a prospective comparison of magnetic resonance spectroscopy and analysis methods for chemical-shift resonance imaging with histologic assessment as the reference standard", Invest Radiol, 47, pp.368~375 (2012)
60. Reeder SB, "Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy", J Magn Reson Imaging, 34, pp.729~749 (2011)
61. Lee SS, "Hepatic fat quantification using chemical shift MR imaging and MR spectroscopy in the presence of hepatic iron deposition: validation in phantoms and in patients with chronic liver disease", J Magn Reson Imaging, 33, pp.1390~1398 (2011)
62. Yokoo T, "Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T", Radiology, 251, pp.67~76 (2009)
63. Yu H, "Combination of complexbased and magnitude-based multiecho water-fat separation for accurate quantification of fat-fraction", Magn Reson Med, 66, pp.199~206 (2011)
64. Meisamy S, "Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy", Radiology, 258, pp.767~775 (2011)
65. Kukuk GM, "Comparison between modified Dixon MRI techniques, MR spectroscopic relaxometry, and different histologic quantification methods in the assessment of hepatic steatosis", Eur Radiol, 25, pp.2869~2879 (2015)
66. Brittenham GM, "Noninvasive measurement of iron:report of an NIDDK workshop", Blood, 101, pp.15~19 (2003)
67. Fujita N, "Hepatic iron accumulation is associated with disease progression and resistance to interferon", ribavirin combination therapy in chronic hepatitis C, 2007, pp.22, 1886~1893
68. Allen KJ, "Iron-overload-related disease in HFE hereditary hemochromatosis", N Engl J Med, 358, pp.221~230 (2008)
69. Rowe JW, "Familial hemochromatosis:characteristics of the precirrhotic stage in a large kindred", Medicine, 56, pp.197~211 (1977)
70. Barry M, "Measurement of liver-iron concentration in needle-biopsy specimens", Lancet, 1, pp.100~103 (1971)
71. Villeneuve JP, "Variability in hepatic iron concentration measurement from needlebiopsy specimens", J Hepatol, 25, pp.172~177 (1996)
72. Papakonstantinou O, "Quantification of liver iron overload by T2 quantitative magnetic resonance imaging in thalassemia: impact of chronic hepatitis C on measurements", J Pediatr Hematol Oncol, 21, pp.142~148 (1999)
73. Sirlin CB, "Magnetic resonance imaging quantification of liver iron", Magn Reson Imaging Clin N Am, 18, pp.359~381 (2010)
74. Alustiza Echeverria JM, "Quantification of iron concentration in the liver by MRI", Insights Imaging, 3, pp.173~180 (2012)
75. Westwood M, "A single breathhold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload", J Magn Reson Imaging, 18, pp.33~39 (2003)
76. Wood JC, "Magnetic resonance imaging measurement of iron overload", Curr Opin Hematol, 14, pp.183~190 (2007)
77. Gandon Y, "Non-invasive assessment of hepatic iron stores by MRI", Lancet, 363, pp.357~362 (2004)
78. Castiella A, "Liver iron concentration quantification by MRI: are recommended protocols accurate enough for clinical practice?", Eur Radiol, 21, pp.137~141 (2011)
79. Clément O, "Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent: kinetic and enhancement patterns in normal and cholestatic rats", Invest Radiol, 27, pp.612~619 (1992)
80. Shimizu J, "Evaluation of regional liver function by gadolinium-EOB-DTPA-enhanced MR imaging", Dig Dis Sci, 44, pp.1330~1337 (1999)
81. Kim T, "Experimental hepatic dysfunction:evaluation by MRI with Gd-EOB-DTPA", J Magn Reson Imaging, 7, pp.683~688 (1997)
82. Van Beers BE, "Primovist, eovist: what to expect?", J Hepatol, 57, pp.421~429 (2012)
83. Tsuda N, "Potential of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)for differential diagnosis of nonalcoholic steatohepatitis and fatty liver in rats using magnetic resonance imaging", Invest Radiol, 42, pp.242~247 (2007)
84. Leonhardt M, "Hepatic uptake of the magnetic resonance imaging contrast agent Gd-EOB-DTPA:role of human organic anion transporters", Drug Metab Dispos, 38, pp.1024~1028 (2010)
85. Verloh N, "Assessing liver function by liver enhancement during the hepatobiliary phase with Gd-EOBDTPA-enhanced MRI at 3 Tesla", Eur Radiol, 24, pp.1013~1019 (2014)
86. Nilsson H, "Assessment of liver function in primary biliary cirrhosis using Gd-EOBDTPA-enhanced liver MRI", HPB, 12, pp.567~576 (2010)
87. Higaki A, "Potential clinical factors affecting hepatobiliary enhancement at Gd-EOB-DTPA-enhanced MR imaging", Magn Reson Imaging, 30, pp.689~693 (2012)
88. Nakamura S, "Chronological evaluation of liver enhancement in patients with chronic liver disease at Gd-EOB-DTPA-enhanced 3-T MR imaging: does liver function correlate with enhancement?", Jpn J Radiol, 30, pp.25~33 (2012)
89. Utsunomiya T, "Possible utility of MRI using Gd-EOB-DTPA for estimating liver functional reserve", J Gastroenterol, 47, pp.470~476 (2012)
90. Nilsson H, "The inhomogeneous distribution of liver function: possible impact on the prediction of post-operative remnant liver function", HPB, 17, pp.272~277 (2015)
91. Kanki A, "Hepatic parenchymal enhancement at Gd-EOB-DTPA-enhanced MR imaging: correlation with morphological grading of severity in cirrhosis and chronic hepatitis", Magn Reson Imaging, 30, pp.356~360 (2012)
92. Katsube T, "Estimation of liver function using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance imaging", Invest Radiol, 46, pp.277~283 (2011)
93. Feier D, "Liver fibrosis: histopathologic and biochemical influences on diagnostic efficacy of hepatobiliary contrast-enhanced MR imaging in staging", Radiology, 269, pp.460~468 (2013)
94. Kato N, "Gadolinium-ethoxybenzyl-diethylenetriamine-pentaacetic acid interaction with clinical drugs in rats", Invest Radiol, 37, pp.680~684 (2002)
95. Nassif A, "Visualization of hepatic uptake transporter function in healthy subjects by using gadoxetic acidenhanced MR imaging", Radiology, 264, pp.741~750 (2012)
96. Sandrasegaran K, "Functional MR imaging of the abdomen", Radiol Clin North Am, 52, pp.883~903 (2014)
97. Varenika V, "Hepatic fibrosis: evaluation with semiquantitative contrast-enhanced CT", Radiology, 266, pp.151~158 (2013)
98. Rosenkrantz AB, "Magnetization transfer contrast-prepared MR imaging of the liver: inability to distinguish healthy from cirrhotic liver", Radiology, 262, pp.136~143 (2012)
99. Allkemper T, "Evaluation of fibrotic liver disease with whole-liver T1rho MR imaging: a feasibility study at 1.5 T", Radiology, 271, pp.408~415 (2014)
100. Rasucher I, "Evaluation of T1rho as a potential MR biomarker for liver cirrhosis: comparison of healthy control subjects and patients with liver cirrhosis", Eur J Radiol, 83, pp.900~904 (2014)
101. Deng M, "Liver T1ρ MRI measurement in healthy human subjects at 3 T: a preliminary study with a two-dimensional fast-field echo sequence", Br J Radiol, 85, pp.e590~e595 (2012)
102. Balarsy C, "Susceptibilityweighted MR imaging in the grading of liver fibrosis: a feasibility study", Radiology, 270, pp.149~158 (2014)
103. Yoon JH, "Combined use of MR Fat quantification and MR elastography in living liver donors: can it reduce the need for preoperative liver biopsy?", Radiology, 276, pp.453~464 (2015)
104. Venkatesh SK, "Magnetic resonance elastography of liver", Magn Reson Imaging Clin N Am, 22, pp.433~446 (2014)

관련 논문AI추천